US Edition
Breckenridge Pharmaceutical announces final FDA approval for Dehydrated Alcohol Injection, USP (generic for Ablysinol®)
Summary by Smith Mountain Eagle
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Breckenridge Pharmaceutical announces final FDA approval for Dehydrated Alcohol Injection, USP (generic for Ablysinol®)
BERKELEY HEIGHTS, N.J., June 24, 2025 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced today that the Food and Drug Administration (FDA) has granted approval…
·Franklin County, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
